Chronic Pain Drugs Market Size, Share & Industry Analysis, By Drug Class (NSAIDs, Opioids, Antidepressants, Anticonvulsants / Gabapentinoids, Topical Analgesics, Local Anesthetics, & Others), By Disease Indication (Musculoskeletal Pain, Neuropathic Pain, Cancer-related Pain, Postsurgical / Post-traumatic Pain, Visceral Pain, & Others), By Age Group (Pediatric & Adult), By Type (Branded & Generic), By Route of Administration (Oral & Parenteral), By Distribution Channel (Hospital Pharmacies, Specialty pharmacies, Drug Stores & Retail Pharmacies, & Others), and Regional Forecast, 2026-2034

Last Updated: April 16, 2026 | Format: PDF | Report ID: FBI115944

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 4.01% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Region
By Drug Class	NSAIDs Opioids Antidepressants Anticonvulsants / Gabapentinoids Topical Analgesics Local Anesthetics Cannabinoid-based Drugs NMDA Receptor Antagonists
By Disease Indication	Musculoskeletal Pain Neuropathic Pain Cancer-related Pain Postsurgical / Post-traumatic Pain Visceral Pain Headache / Orofacial Pain Primary Pain Syndromes Others
By Age Group	Pediatric Adults
By Type	Branded Generic
By Route of Administration	Oral Parenteral
By Distribution Channel	Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies Others
By Region	North America (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa